MedTrace Logo

Effect of Captopril on GLS in Duchenne Myodystrophy

NCT06485661 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-16

No results posted yet for this study

Summary

To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD)

Conditions

  • Effect of Drug

Interventions

DRUG

Captopril Tablets

Patients will be given captopril to see effect on global longitudinal strain

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mona Mostafa Rayan, MD · Professor of cardiology -Ain Shams university

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06485661 on ClinicalTrials.gov